SanBio Company Limited provided consolidated earnings guidance for the fiscal year ending January 31, 2022. For the period, the company expects operating loss of JPY 5,786 million, ordinary loss of JPY 5,876 million and net loss attributable to owners of parent of JPY 5,877 million or JPY 113.49 per share.